(Q38194990)

30 August 2017

Duration of the pre-diagnostic interval in medulloblastoma is subgroup dependent (English)

1 reference

30 August 2017

0 references

8

Uri Tabori

0 references

Claudia C Faria

Claudia C Faria

6

0 references

Xin Wang

Xin Wang

4

0 references

Vijay Ramaswamy

Vijay Ramaswamy

1

0 references

Marc Remke

Marc Remke

2

0 references

Eric Bouffet

12

Eric Bouffet

1 reference

30 August 2017

9

Cynthia Hawkins

1 reference

30 August 2017

5

Paul A Northcott

1 reference

30 August 2017

10

James Rutka

1 reference

30 August 2017

David Shih

3

1 reference

PubMed ID

24616042

30 August 2017

Charles Raybaud

7

1 reference

PubMed ID

24616042

30 August 2017

Michael D Taylor

11

1 reference

30 August 2017

25 February 2014

1 reference

30 August 2017

Pediatric Blood Cancer

1 reference

30 August 2017

61

1 reference

30 August 2017

7

1 reference

30 August 2017

1190-1194

1 reference

FISH and chips: the recipe for improved prognostication and outcomes for children with medulloblastoma.

30 August 2017

1 reference

Parents' accounts of obtaining a diagnosis of childhood cancer.

21 January 2018

1 reference

A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma

21 January 2018

1 reference

Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcome

21 January 2018

1 reference

Delays in diagnosis of paediatric cancers: a systematic review and comparison with expert testimony in lawsuits

21 January 2018

1 reference

Does diagnostic delay result in decreased survival in paediatric brain tumours?

21 January 2018

1 reference

Interval between onset of symptoms and diagnosis of medulloblastoma in children: distribution and determinants in a population-based study

21 January 2018

1 reference

The time to diagnosis in childhood lymphomas and other solid tumors.

21 January 2018

1 reference

Medulloblastomics: the end of the beginning

21 January 2018

1 reference

Medulloblastoma comprises four distinct molecular variants

21 January 2018

1 reference

Molecular subgroups of medulloblastoma: the current consensus

21 January 2018

1 reference

FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma

21 January 2018

1 reference

Subgroup-specific alternative splicing in medulloblastoma

21 January 2018

1 reference

Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma

21 January 2018

1 reference

Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct

21 January 2018

1 reference

Subgroup-specific structural variation across 1,000 medulloblastoma genomes

21 January 2018

1 reference

Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.

21 January 2018

1 reference

The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors

21 January 2018

1 reference

Clonal selection drives genetic divergence of metastatic medulloblastoma

21 January 2018

1 reference

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas

21 January 2018

1 reference

Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome

21 January 2018

1 reference

Adult medulloblastoma comprises three major molecular variants.

21 January 2018

1 reference

The clinical implications of medulloblastoma subgroups

21 January 2018

1 reference

Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis

21 January 2018

1 reference

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

21 January 2018

1 reference

Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples

21 January 2018

1 reference

Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations

21 January 2018

1 reference

Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma

21 January 2018

1 reference

Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma.

21 January 2018

1 reference

TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma.

21 January 2018

1 reference

Brain tumors in children: initial symptoms and their influence on the time span between symptom onset and diagnosis.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PBC.25002

1 reference

30 August 2017

1 reference

PubMed ID

24616042